Inovio and Collaborators Receive NIH Grantto Evaluate HIV Immunotherapy PENNVAX-GPs Abilityto Induce … – EconoTimes
|
Inovio and Collaborators Receive NIH Grantto Evaluate HIV Immunotherapy PENNVAX-GPs Abilityto Induce …
EconoTimes Development of Inovio's PENNVAX-GP immunotherapy, which widely targets multiple major clades of HIV — providing global coverage — has been funded through a $25 million NIAID contract awarded to Inovio and its collaborators. In addition, Inovio and … |
